0T5 Stock Chart & Stats
€71.85
€1.50(2.18%)
At close: 4:00 PM EDT
€71.85
€1.50(2.18%)
Day’s Range― - ―
52-Week Range€48.96 - €118.00
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€1.15B
Enterprise Value€1.78B
Total Cash (Recent Filing)€268.31M
Total Debt (Recent Filing)€310.67M
Price to Earnings (P/E)27.1
Beta0.79
Next Earnings
Nov 11, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.38
Shares Outstanding20,048,922
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)5.60
Price to Sales (P/S)4.29
P/FCF Ratio45.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€101.73Price Target Upside41.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.12
Revenue Forecast (FY)€502.77M
Bulls Say, Bears Say
Bulls Say
Modern Oral GrowthRapid Modern Oral growth is shifting TPB toward a category with expanding consumer adoption and increasing revenue contribution. The momentum, supported by broader retail distribution and direct-to-consumer channels, can strengthen scale, brand visibility, and future earnings power over the next several quarters.
Improved Balance SheetThe substantial reduction in leverage and growth in equity provide TPB with a stronger capital base than in prior years. Lower financial risk improves resilience and preserves greater flexibility to fund Modern Oral expansion, regulatory work, and other strategic investments.
Retail Distribution ExpansionA large increase in chain-store distribution can expand product availability, improve shelf visibility, and support recurring replenishment across TPB's brands. Incremental placements also give Modern Oral products more opportunities to convert consumer demand into sustained retail sales.
Bears Say
Weak Cash ConversionCash generation is currently weak relative to reported earnings, which may indicate working-capital or timing pressure. If this persists, TPB could have less internally generated funding for growth initiatives and reduced flexibility to absorb operating volatility or regulatory spending.
Earnings Investment PressureHeavy investment in sales and marketing is temporarily compressing EBITDA and could keep near-term earnings below the pace of revenue growth. The strategy may build durable brands, but it also raises execution risk if distribution expansion does not generate sufficient incremental returns.
PMTA Regulatory UncertaintyUncertain FDA timing creates a continuing risk to product commercialization and the planned expansion of nicotine pouch capabilities. The required regulatory effort also adds costs before approval, while delays could postpone manufacturing benefits and limit the pace of category growth.
0T5 FAQ
What was Turning Point Brands’s price range in the past 12 months?
Turning Point Brands lowest stock price was €48.96 and its highest was €118.00 in the past 12 months.
What is Turning Point Brands’s market cap?
Turning Point Brands’s market cap is €1.15B.
When is Turning Point Brands’s upcoming earnings report date?
Turning Point Brands’s upcoming earnings report date is Nov 11, 2026 which is in 19 days.
How were Turning Point Brands’s earnings last quarter?
Turning Point Brands released its earnings results on Aug 04, 2026. The company reported €0.161 earnings per share for the quarter, beating the consensus estimate of €0.103 by €0.057.
Is Turning Point Brands overvalued?
According to Wall Street analysts Turning Point Brands’s price is currently Undervalued.
Does Turning Point Brands pay dividends?
Turning Point Brands does not currently pay dividends.
What is Turning Point Brands’s EPS estimate?
Turning Point Brands’s EPS estimate is 0.17.
How many shares outstanding does Turning Point Brands have?
Turning Point Brands has 20,048,922 shares outstanding.
What happened to Turning Point Brands’s price movement after its last earnings report?
Turning Point Brands reported an EPS of €0.161 in its last earnings report, beating expectations of €0.103. Following the earnings report the stock price went up 7.197%.
Which hedge fund is a major shareholder of Turning Point Brands?
Currently, no hedge funds are holding shares in DE:0T5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Turning Point Brands Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€101.73 (41.58% Upside)
€101.73 (41.58% Upside)
Blogger Sentiment
Neutral
DE:0T5 Sentiment 57%
Sector Average 64%
Sector Average 64%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.02%
12-Months-Change
Fundamentals
Return on Equity
11.93%
Trailing 12-Months
Asset Growth
43.54%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Turning Point Brands
Turning Point Brands, Inc., along with its affiliated companies, is engaged in the creation, promotion, and distribution of a diverse array of branded consumer products. Its operations are structured into three distinct divisions: Zig-Zag Products, Stoker's Products, and NewGen Products. The Zig-Zag Products division focuses on the marketing and distribution of rolling papers, cigarette tubes, pre-rolled cigars, 'make-your-own' cigar wraps, and related accessories, all sold under the well-known Zig-Zag brand. Conversely, the Stoker's Products division is responsible for manufacturing and commercializing moist snuff and loose-leaf chewing tobacco products. These are offered under several brand names including Stoker's, Beech-Nut, Durango, Trophy, and Wind River. The NewGen Products segment caters to individual consumers by marketing and distributing cannabidiol (CBD) isolate, liquid vapor items, and various other offerings free from tobacco and/or nicotine. This is achieved through its direct-to-consumer online platform, VaporFi, and its non-traditional retail outlet, VaporBeast. TPB's goods are supplied to a broad network of wholesale distributors and retail partners, encompassing independent and chain convenience stores, specialized tobacco shops, grocery stores, major retailers, and pharmacies. Originally established as North Atlantic Holding Company, Inc., the corporation adopted its current name, Turning Point Brands, Inc., in November 2015. Founded in 1988, Turning Point Brands, Inc. maintains its corporate headquarters in Louisville, Kentucky.
0T5 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly optimistic, led by substantial Modern Oral growth, raised Modern Oral revenue guidance, expanding retail distribution, positive ALP traction, and continued investment in long-term brand and manufacturing capabilities. These positives outweighed lower adjusted EBITDA, higher SG&A, Zig-Zag softness, lower heritage revenue, reduced Stoker's gross margin, and PMTA timing uncertainty.View all DE:0T5 earnings summaries0T5 Stock 12 Month Forecast
Average Price Target
€101.73
▲(41.58% Upside)
Technical Analysis
Altria Group
―
British American Tobacco
―
Philip Morris
―
22nd Century
―
RLX Technology
―








